VIAV institutional options flow analysis — multi-leg block trades, dominant direction, and gamma analysis from the public options tape for April 27, 2026. Articles older than 60 days are public; a free account reads back to 30 days, Pro to 5, and AIme Premium reads today's unusual options trades with no delay.

VIAV Unusual Options Activity — 2026-04-27

Institutional flow on 2026-04-27

Multi-leg block trades, dominant direction, and gamma analysis

$4.4M2 trades
Short CallShort Put

Trade Details

SELL$42 PUT2026-05-15$2.8MShort Put
SELL$55 CALL2026-05-15$1.6MShort Call

Full Analysis

💰 VIAV $4.4M Short Strangle — Smart Money Sells IV Crush 2 Days Before Earnings

April 27, 2026 | Unusual Options Activity Detected


Meta

  • Ticker: VIAV (Viavi Solutions, NASDAQ)
  • Date: April 27, 2026
  • Strategy: Short Strangle — SELL PUT $42 + SELL CALL $55, May 15 expiration
  • Total Credit Collected: $4.4M
  • Earnings: FQ3 FY26 — Wednesday, April 29, 2026 (after market close)
  • Days to Expiration: 18 (as of April 27)
  • Current Spot: $45.17

The Quick Take

With VIAV's FQ3 FY26 earnings hitting the tape Wednesday April 29 after close — just 2 trading days away — a single institution placed a $4.4 million SHORT STRANGLE at 12:49:53 today. They simultaneously sold 8,550 contracts of the May 15 $42 put (collecting $2.8M) and 8,550 contracts of the May 15 $55 call (collecting $1.6M), both in the same second at the same expiration.

This is a pure implied-volatility harvest. The trader is not betting on direction — they are betting that VIAV stays inside a $42–$55 range through May 15, collecting $4.4 million in premium upfront. The thesis: options are juiced to extremes ahead of the print, and once earnings pass, IV will collapse, evaporating the time value they just sold.

The risk is not subtle. A short strangle has uncapped loss potential on both tails. If VIAV gaps above $55 on a massive beat (or below $42 on a disaster), losses mount without limit. This is a high-conviction, high-risk institutional trade — not a retail strategy to copy without careful position sizing and defined-risk hedges.


Company Overview

Viavi Solutions (NASDAQ: VIAV) is a $10–11 billion market-cap network test and measurement company undergoing one of the most dramatic business-model transformations in its history.

Historically a telco-capex name, VIAV has repositioned itself at the intersection of two 2026 growth narratives — AI data-center optical/Ethernet testing and defense/PNT (Position-Navigation-Timing) — via two transformational acquisitions:

The Q2 FY26 print (January 28, 2026) was the inflection: NSE revenue grew 46% YoY to $291.5M, with the segment mix now roughly 45% data center, 40% service provider, and 15% aerospace and defense — a remarkable rotation away from pure telco exposure. Non-GAAP operating margin reached 19.3%, well above the guided 17.3%–18.5% range.

The stock has responded accordingly: +289.7% over the trailing 12 months, with shares trading near $45 today versus $23–$24 just months ago.

Key Products: Network and Service Enablement (NSE) instruments, software, and assurance platforms; TestCenter D2 1.6T appliance for AI data-center validation; Optical Security Products (OSP) including color-shifting banknote pigments used by 100+ governments worldwide.


The Tape

TimeSymbolSideBuy/SellTypeExpirationPremiumStrikeVolumeOISizeSpotOption PriceOrder TypeStrategy
12:49:53VIAVSell to OpenSELLPUT $422026-05-15$2.8M$42.0011,0001048,550$45.17$3.30STOShort Strangle (Put Leg)
12:49:53VIAVSell to OpenSELLCALL $552026-05-15$1.6M$55.0011,0002,6008,550$45.17$1.90STOShort Strangle (Call Leg)

What the simultaneous timestamps confirm: Both legs printed at 12:49:53 — the same second, same expiration, same contract count. This is one coordinated institutional trade, not two unrelated positions. The Z-scores of 592 (put leg) and 15 (call leg) classify this as EXTREMELY UNUSUAL flow.

Strike geometry:

  • $42 put is 7.0% out-of-the-money below spot $45.17 — put leg collects $3.30/share ($2.8M total)
  • $55 call is 21.8% out-of-the-money above spot $45.17 — call leg collects $1.90/share ($1.6M total)
  • Total credit received: $5.20/share gross across both legs = $4.4M CREDIT
  • The asymmetric positioning (put much closer OTM) suggests the trader is slightly more concerned about downside than upside, but still expects the stock to hold above $42 post-earnings

Technical Setup

YTD Performance

VIAV YTD Chart

VIAV has been one of the highest-momentum names in tech in 2026. Shares have surged +289.7% over the trailing 12 months, with a particularly violent re-rating following the Q2 FY26 beat on January 28, 2026. The stock hit an all-time closing high of $44.13 on April 17 per Macrotrends, and is now trading just above $45 — meaning the short put at $42 sits only 7% below an all-time-high zone.

The 2-week gain of +28.2% into this earnings period reflects aggressive pre-earnings positioning, which is precisely why implied volatility is elevated and why selling premium here is attractive to large desks. The risk: a post-earnings flush on any disappointment from a stock at all-time highs can be violent, and the $42 put strike has very limited cushion in that scenario.

Gamma Support and Resistance

VIAV Gamma Support & Resistance

The gamma exposure map places $45 as the strongest nearby support (total GEX 0.353, net GEX -0.076), sitting just $0.17 below current spot. This is a double-edged signal: market makers are pinned near $45 for now, but below $45 the next gamma cluster is at $44 (net GEX +0.169) and $40 (total GEX 0.541) — which coincides with important psychological support.

Key support levels (below spot):

StrikeTotal GEXNet GEXDistance from Spot
$450.353-0.0760.2%
$440.240+0.1692.4%
$420.058+0.0226.9% (SHORT PUT STRIKE)
$400.541-0.09611.3%

Key resistance levels (above spot):

StrikeTotal GEXNet GEXDistance from Spot
$470.292+0.1644.2%
$490.082+0.0718.6%
$501.041+1.02410.9% (MASSIVE WALL)

The $50 strike is by far the largest resistance level (total GEX 1.041, dominantly call-sided), sitting 10.9% above spot. This is significant: the short $55 call strike is well above even the heaviest call gamma concentration, suggesting the call seller sees $55 as nearly unreachable before May 15. Meanwhile, the $42 put strike sits in relatively thin gamma territory (total GEX 0.058), meaning there is less natural market-maker hedging support at that level — a gap in the floor.

Overall GEX bias: Bullish (4.15 total call GEX vs. 1.45 total put GEX). The options market leans constructive on the stock, which is consistent with the strangle seller's asymmetric premium structure (more credit on the put side reflects higher put IV, not necessarily more expected downside).

Implied Move Analysis

VIAV Implied Move

The options market is pricing an 18.39% implied move ($8.29) through May 15 expiration from a spot of $45.08, giving an options-implied range of $36.79 to $53.36.

TimeframeExpiryImplied MoveUpper RangeLower Range
Monthly OPEXMay 15, 2026±18.39% / ±$8.29$53.36$36.79
Yearly LEAPSMar 19, 2027±54.4% / ±$24.52$69.60$20.55

What this means for the strangle:

The at-the-money straddle is pricing a ~$8.29 move by May 15. The short strangle collects only $5.20 per share across both legs — meaning the market is pricing a move considerably larger than the premium collected. The strangle seller is explicitly disagreeing with the options market's implied move estimate, betting the realized move will be smaller than 18.4%.

  • The $55 call strike is at $53.36 + $1.64 = comfortably above the upper implied range boundary. The call side appears to have ample cushion.
  • The $42 put strike is BELOW the lower implied range of $36.79... wait — the lower range is $36.79, which is below $42. This means the options market is actually pricing a scenario where the stock breaks below the short put strike. The put seller is collecting $3.30 for a strike that sits inside the tails of the options-implied distribution.

This framing makes the downside risk transparent: the $42 put is not deeply safe relative to what IV is pricing. The trader is accepting roughly a 15–20% probability of assignment on that put leg at expiration, in exchange for $3.30 of premium and the bet that actual realized volatility undershoots the market's fear pricing.


Catalysts

The Earnings Print — FQ3 FY26, Wednesday April 29 AMC

The FQ3 FY26 earnings release is confirmed for Wednesday, April 29, 2026 after market close, webcast at 4:30 p.m. ET. Management's own guidance — which functions as the de facto consensus bar — is:

  • Revenue: $386M–$400M
  • Non-GAAP EPS: $0.22–$0.24
  • NSE: $304M–$316M; NSE operating margin guided 15.5% ± 50 bps
  • OSP: $82M–$84M

Key metrics the market will scrutinize on April 29:

  1. Spirent revenue contribution and integration progress — The Spirent acquisition is now running at ~$200M annualized run-rate, above the original $188M expectation. Any commentary on cross-sell traction or customer retention will be closely watched.
  2. Data-center percent of NSE mix — Was 45% in Q2 FY26 (up from near-zero 18 months ago). Sustained or accelerating data-center share is the core re-rating thesis.
  3. 1.6T appliance ramp commentary — The TestCenter D2 1.6T appliance launched at OFC 2026 in March alongside a partnership demo with Infraeo on 800G/1.6T AI links. Pipeline conversion to bookings is the next proof point.
  4. FY26 full-year framework refresh — Any upward revision to revenue or margin guidance will be the catalyst to push through $50 resistance.
  5. Restructuring timing and free cash flow — The January 2026 restructuring plan (5% workforce reduction, $32M charges, ~$30M annualized savings including $16M of Spirent integration synergies) should be well advanced — is free cash flow improving post the $425M Spirent cash outlay?

Spirent Integration — $200M Run-Rate Already Exceeding Targets

The Spirent deal is the single largest variable in the VIAV growth equation. VIAV closed the all-cash $425M acquisition on October 16, 2025, bringing in high-speed Ethernet, network-security testing, and channel-emulation capabilities that had previously been Keysight's post the Spirent Communications acquisition. The run-rate is now ~$200M annualized, already outpacing the original $180M first-year projection. Full synergy realization of the $30M annualized restructuring savings is expected to complete by end of calendar year 2026.

AI Data-Center and 1.6T Ethernet Tailwind

The core bull narrative centers on VIAV's positioning as the validation layer for hyperscaler AI fabric buildouts. The company debuted the TestCenter D2 1.6T appliance at OFC 2026 in March alongside an INX 700 probe microscope and high-density OSFP 1.6T platform. As hyperscalers migrate from 400G to 800G/1.6T Ethernet for AI back-end fabric, every NEM (network equipment manufacturer) qualification cycle requires instruments that only VIAV now broadly offers at scale in this segment. The market opportunity in wireless network test equipment alone is sized at $4.91B with 7.4% CAGR through 2029, with optical/Ethernet test layered on top.

Analyst Price Targets

AnalystFirmRatingPrice TargetDate
B. RileyBuy$53April 24, 2026
Northland SecuritiesBuy$50April 20, 2026
RosenblattBuy$42Recent
Stifel$35Recent

Both B. Riley and Northland essentially doubled their price targets in the same week (B. Riley raised from $26 to $53 on April 24; Northland raised from $27.50 to $50 on April 20), reflecting a broad analyst community repricing of the growth algorithm post-Spirent and post-Q2 FY26. Rosenblatt's $42 target is notable — it sits exactly at the short put strike.


Trading Ideas

The short strangle as filed is a sophisticated institutional income trade with a specific thesis: that post-earnings IV collapse will erase most of the time value in both the put and call legs before meaningful adverse price movement can occur. Here is how retail traders should contextualize the trade and their own potential approaches:

Understanding the institutional trade's logic:

The trader collected $4.4M in gross credit to define a $42–$55 profit zone on a $45.17 stock. The maximum profit of $4.4M is achieved if VIAV closes anywhere between $42 and $55 on May 15. Below $42, losses begin on the put side — and they are uncapped until VIAV goes to zero. Above $55, losses begin on the call side — and they are uncapped as the stock rises. The IV crush post-earnings (typically 30–50% IV decline the day after the print) is the primary mechanism expected to generate rapid profit on both legs.

Conservative approach — stay on the sidelines for this one:

The short strangle is inappropriate for most retail accounts. It requires substantial margin (typically 20–25% of underlying notional per naked leg), real-time monitoring capability, and the ability to sustain losses that can exceed the premium collected many times over if the stock gaps through a strike on earnings. Given that the FQ3 print is 2 days away and the stock has rallied +28.2% in just 2 weeks, the binary risk is acute. Waiting for the earnings reaction to settle before initiating any position is the most prudent course.

Defined-risk alternative — iron condor (for experienced options traders only):

If the thesis is IV crush and range-bound trading post-earnings, a retail-friendly way to participate is through a defined-risk iron condor:

  • Sell the May 15 $42 put / Buy the May 15 $38 put (put spread)
  • Sell the May 15 $55 call / Buy the May 15 $59 call (call spread)

This structure caps the maximum loss at the width of either spread ($4.00) minus the net credit collected, rather than exposing the account to open-ended losses. The trade-off is that the maximum credit is reduced relative to the naked strangle. However, defined maximum loss is appropriate for most individual investors considering any premium-selling strategy over earnings.

Important: Enter iron condors only after the earnings reaction is known, not before — or accept that the pre-earnings elevated IV means better credit collection but binary gap risk.

Equity context — the bull case remains intact:

For those with a long-term equity view on VIAV, the strangle flow is not a bearish signal on the stock. It is an income and IV-crush trade. The B. Riley $53 and Northland $50 targets suggest meaningful upside from current levels if FQ3 delivers a beat-and-raise. The $50 gamma wall identified above acts as a natural price magnet in that scenario.


Risk Factors

Uncapped loss on both tails — the defining risk of a short strangle:

Unlike a credit spread or iron condor, the naked short strangle has no defined maximum loss. If VIAV gaps below $42 on a severe earnings miss, the short $42 put loses $1 for every $1 the stock falls below $42. If VIAV gaps above $55 on a massive beat-and-raise with hyperscaler design-win disclosures, the short $55 call loses $1 for every $1 the stock rises above $55. There is no ceiling on the call loss and a floor only at zero on the put loss. This is the fundamental asymmetry every trader must internalize before selling naked options over earnings.

Valuation risk into a high bar:

The stock has risen +289.7% over 12 months and +28.2% in just the last 2 weeks. At approximately 7x forward EV/Sales and ~50x forward P/E, the valuation leaves minimal margin for error. Even an in-line April 29 print — with no guidance raise — may disappoint a market that has priced in a beat-and-raise. A modest guide-down could trigger a 15–25% drawdown, threatening the $42 put strike.

Spirent integration execution risk:

The Spirent transaction is the largest acquisition in VIAV's recent history and brings ~$200M of revenue across multiple product lines, sales channels, and geographies. Synergy capture timing, customer attrition during the integration, and the simultaneous 5% workforce reduction add operational complexity. Any integration hiccup disclosed on April 29 would weigh on NSE margin guidance.

Telecom capex structural headwind:

Dell'Oro projects worldwide telecom capex at -2% in 2026 with only 1% CAGR through 2030. The 40% of NSE revenue still tied to service-provider accounts is directly exposed. If data-center growth decelerates even slightly, the telecom headwind could become visible in the overall NSE growth rate.

Short interest spike — smart money sees downside risk too:

Short interest rose 21.6% in mid-March 2026 to 14.76M shares, representing ~6.5% of float. This is not trivial. Short sellers positioning ahead of an earnings print that many view as a sell-the-news event are providing a real counter-narrative to the bull case.

Insider selling — heavy and sustained:

CEO Oleg Khaykin sold 70,566 shares at ~$27 average on February 6, 2026; total insider sales over the trailing 90 days totaled ~$12.7M. While these are programmatic sales, the pace has not slowed despite the stock tripling. Insiders own only ~1.80% of the company.

The $42 put strike is inside the options-implied range:

The May 15 implied move of ±18.39% gives a lower bound of $36.79 — which is below the $42 short put strike. In simple terms, the options market is pricing a scenario in which VIAV falls through $42. The short put seller is getting paid $3.30 to disagree with that probability assessment. If the market is right, the put will be in-the-money at expiration.

Geopolitical and macro risk:

Despite China's SAMR approval of the Spirent divestiture, escalating US-China technology tensions could pressure cross-border test and measurement sales. VIAV's anti-counterfeiting OSP business depends on sovereign relationships. A 2026 macro slowdown would compress hyperscaler capex deployment cadence even if AI investment remains a stated priority.


Bottom Line

A single institution walked into the market today and sold $4.4 million worth of options volatility on VIAV — collecting premium on both sides of the stock, 48 hours before a high-stakes earnings print. The simultaneous 8,550-contract sale of the May 15 $42 put ($2.8M credit) and May 15 $55 call ($1.6M credit) is a textbook pre-earnings IV harvest: take in maximum premium when fear is highest, collect the bulk of it as IV collapses post-earnings, and walk away before the options market re-prices.

The setup has clear logic. VIAV is up +289.7% in 12 months. The earnings setup is real: NSE grew 46% YoY in Q2 FY26, the Spirent acquisition is running above its $180M first-year revenue target at ~$200M, and both B. Riley ($53) and Northland Securities ($50) have essentially doubled their price targets in the same week. The $50 gamma wall creates a natural ceiling for near-term upside. The $42 put is 7% below spot and sits at a level where even Rosenblatt's conservative $42 price target provides rough fundamental support.

But the risks are not subtle. This is an uncapped-loss trade. The options-implied range for May 15 extends down to $36.79 — below the short put strike — meaning the probability of put assignment at expiration is not negligible. A gap below $42 on an earnings miss, Spirent integration setback, or broad market drawdown would generate losses that grow linearly with every dollar the stock falls. Similarly, a blow-out beat-and-raise with explicit hyperscaler 1.6T design-win announcements could push VIAV above $53–$55 before IV crush can rescue the position.

The strangle seller is making a high-conviction bet that VIAV's realized volatility post-earnings will be smaller than its current implied volatility. History generally favors that bet in equities — realized vol tends to trail implied vol over most earnings windows. But VIAV at all-time highs, +28% in 2 weeks, with a stock that has tripled in a year, is not a typical volatility seller's candidate. The asymmetric put positioning (put strike much closer to spot than the call strike) tells you the risk manager on this trade knows exactly which tail they are most exposed to.

For retail participants: watch April 29 after close. If VIAV reports in-line to above-guidance results — particularly with constructive data-center mix and Spirent commentary — the stock likely consolidates in the $44–$52 range through May 15, and this strangle collects most of its $4.4M credit. If the print disappoints on NSE margin or guidance, the post-earnings flush toward $40–$42 is the scenario that turns this trade painful in a hurry.


Disclaimer: Options trading involves substantial risk of loss and is not suitable for all investors. This analysis is for informational and educational purposes only and does not constitute financial advice or a recommendation to buy or sell any security. Short strangles involve uncapped loss potential and substantial margin requirements, and are inappropriate for most retail investors without explicit defined-risk structures. Past performance does not guarantee future results. Always conduct your own due diligence and consult a licensed financial professional before initiating any options position.

The Options Desk tracks the move options price into every US earnings report the week of Sep 7, next to how much each stock has actually moved on its past prints — plus the SPY, QQQ and IWM expected ranges and the gamma walls that box them in.